Chemed CHE
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$8.08M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 4.91% to 6.14% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +96,311 | 2.9% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +68,470 | 6.6% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +46,403 | 0.4% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +43,304 | 0.3% |
| Fideuram Asset Management (Ireland) DAC | Mutual Fund | 2026/Q3 | +31,183 | 0.2% |
| Thrivent Investment Management, Inc. | Mutual Fund | 2026/Q3 | +26,053 | 0.2% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +25,107 | 0.2% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +23,521 | 2.0% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +552,596 | 7.5% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +259,114 | 2.2% |
| River Road Asset Management, LLC | Mutual Fund | 2026/Q3 | +166,159 | 1.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +147,592 | 11.4% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +146,352 | 3.5% |
| SG Americas Securities, LLC | Private Company | 2026/Q3 | +105,288 | 1.0% |
| Fuller & Thaler Asset Management, Inc. | Mutual Fund | 2026/Q3 | +92,595 | 1.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Nov 2026 | Spencer Lee | Executive Vice President | Open Market Disposition | -1,000 | $547.61 | 12,931 |
| 2 Nov 2026 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $537.90 | 82,220 |
| 1 Nov 2026 | Spencer Lee | Executive Vice President | Open Market Disposition | -920 | $537.17 | 13,931 |
| 19 Oct 2026 | Kevin McNamara | Chief Executive Officer | Other Derivative Acquisition | +36,693 | $512.64 | 300,851 |
| 19 Oct 2026 | Spencer Lee | Executive Vice President | Other Derivative Acquisition | +7,125 | $512.64 | 23,222 |
| 19 Oct 2026 | Thomas Hutton | Officer | Other Derivative Acquisition | +3,964 | $512.64 | 26,053 |
| 19 Oct 2026 | Michael Witzeman | Executive VP, Controller, Principal Accounting Officer & CFO | Other Derivative Acquisition | +12,686 | $512.64 | 66,656 |
| 19 Oct 2026 | Brian Judkins | VP, Secretary & Chief Legal Officer | Other Derivative Acquisition | +9,392 | $512.64 | 40,673 |
| 19 Oct 2026 | Joel Wherley | Executive VP and President & CEO of VITAS Healthcare | Other Derivative Acquisition | +12,686 | $512.64 | 42,906 |
| 29 Sep 2026 | Spencer Lee | Executive Vice President | Derivative Exercise and Sale | -11,160 | $508.93 | 14,851 |
| 29 Sep 2026 | Spencer Lee | Executive Vice President | Derivative Exercise and Retained | +939 | $445.35 | 14,851 |
| 27 Sep 2026 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $513.45 | 66,418 |
| 27 Sep 2026 | Thomas Hutton | Officer | Derivative Exercise and Sale | -4,270 | $506.65 | 80,321 |
| 27 Sep 2026 | Thomas Hutton | Officer | Derivative Exercise and Retained | +359 | $445.35 | 80,321 |
| 17 Sep 2026 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $501.40 | 68,418 |
| 20 Aug 2026 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $541.16 | 70,418 |
| 20 Aug 2026 | Spencer Lee | Executive Vice President | Open Market Disposition | -1,000 | $541.04 | 13,912 |
| 9 Aug 2026 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Sale | -5,878 | $548.96 | 3,344 |
| 9 Aug 2026 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Retained | +908 | $445.35 | 3,344 |
| 4 Aug 2026 | Joel Wherley | Executive VP and President & CEO of VITAS Healthcare | Derivative Exercise and Sale | -2,270 | $542.62 | 1,181 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 795,988 | 6.1% | 5.1 |
| 15 Oct 2026 | 685,972 | 5.3% | 4.9 |
| 30 Sep 2026 | 596,751 | 4.6% | 3.3 |
| 15 Sep 2026 | 653,250 | 5.0% | 5.4 |
| 31 Aug 2026 | 564,624 | 4.3% | 3.8 |
| 14 Aug 2026 | 638,408 | 4.9% | 3.7 |
No comments yet — be the first to weigh in on CHE.
Sign in to join the discussion.